CSL Behring Australia commences development of treatment for serious cases of COVID-19

6 May 2020 - Plasma-derived therapeutic with potential to treat serious complications of COVID-19. ...

Read more →

Australia lacks vaccine making capacity, Defence report warns

6 May 2020 - Australia lacks the facilities and know-how to make its own pandemic vaccines, a report to government ...

Read more →

COVID-19: potentially life saving immunoglobulin treatment for seriously ill Australians

6 May 2020 - The Australian Government welcomes the announcement by CSL Behring that Australia will be one of the first ...

Read more →

CSL ramps up development of COVID-19 plasma treatment

6 May 2020 - Australia’s biggest health company CSL has confirmed it will immediately begin development of plasma-derived therapy to ...

Read more →

Bill Gates to spend billions on coronavirus vaccine development

5 April 2020 - Foundation to help build factories for the seven makers of the most-promising efforts. ...

Read more →

Proposed changes to research and development tax incentive will discourage investment and undermine innovation

6 December 2019 - Medicines Australia is disappointed that proposed changes to the Research and Development Tax Incentive were tabled ...

Read more →

Public sector financial support for late stage discovery of new drugs in the United States: cohort study

23 October 2019 - This study determined the extent to which late stage development of new drugs relies on support from ...

Read more →

Azar's plan to tie U.S. drug prices to foreign ones will impact investments in R&D

21 June 2019 - Americans, be they Republicans or Democrats, are outraged by the rising cost of prescription drugs.  ...

Read more →

Medicines Australia welcomes ALP R&D investment pledge

8 May 2019 - Medicines Australia welcomes today’s announcement from the Australian Labor Party to reform the Research and Development ...

Read more →

FDA advances the science of patient input by seeking specific feedback on patient preferences that may impact regulatory decisions on medical devices

2 May 2019 - The U.S. FDA today opened a docket to receive input from stakeholders on a new priority ...

Read more →

China pharma must swallow that jagged little pill called R&D as government slashes profit margins of generic drugs

19 January 2019 - New policy environment demanding cheaper drugs adds pressure to innovate. ...

Read more →

Medical device development tools: helping to speed medical device evaluation and approval

24 October 2017 - The FDA relies on sound science in its decision-making, which provides medical device innovators with a ...

Read more →

Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to advance medical device innovation and help patients gain faster access to beneficial technologies

24 October 2017 - Enabling patients and providers to have efficient access to new and innovative medical products that meet ...

Read more →

Therapeutic Development a key focus of the Roadmap

15 May 2017 - The Medical Technology Association of Australia welcomes the 2016 National Research Infrastructure Roadmap and its recommendations, ...

Read more →

Draft clinical evidence guidelines - medical devices

15 March 2016 - The TGA is seeking comments from interested parties on the draft Medical Devices Clinical Evidence Guidelines. ...

Read more →